Global Oncology Ablation Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Oncology Ablation Market Expected To Become By 2029 Compared With Its 2025 Level?

The oncology ablation market has experienced significant expansion in recent years. It is projected to increase from $1.3 billion in 2024 to $1.45 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.1%. The historical growth can be attributed to several factors, including the rising incidence of cancer, an increasing preference for minimally invasive ablation techniques, higher healthcare spending, the approval of new ablation devices and technologies, improvements in cancer screening programs, and the expansion of the geriatric population.

The oncology ablation market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $2.33 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.5%. This projected growth during the forecast timeframe stems from several factors, including continuous progress in ablation techniques, greater utilization of ablation methods in developing nations, the expansion of personalized and precision medicine, increased government backing and financial provisions for cancer research and treatment breakthroughs, a growing preference for outpatient medical interventions, and heightened public and professional understanding. Key developments anticipated in the forecast period encompass the incorporation of artificial intelligence (AI), enhancements in imaging technologies, the emergence of robotic-assisted ablation, the launch of sophisticated ablation devices offering superior efficacy, safety, and ease of use, and the application of telemedicine for pre- and post-ablation care, facilitating remote oversight and subsequent consultations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Are The Top Growth Drivers Impacting The Oncology Ablation Market Outlook?

The future expansion of the oncology ablation market is anticipated to be driven by the rising frequency of cancer diagnoses. Cancer diagnosis involves identifying and confirming cancer’s presence through medical testing, imaging, and pathological examination of tissue samples. This increase in diagnoses stems from factors like aging demographics, enhanced screening initiatives, greater awareness promoting early detection, and environmental influences. Oncology ablation serves as a treatment for tumors identified via cancer diagnoses, providing minimally invasive approaches to eradicate tumors and enhance patient results. For example, the National Cancer Institute, the US-based federal government’s main agency for cancer research and training, reported in May 2024 that approximately 2,001,140 new cancer cases are projected in the United States in 2024, with prostate, lung, and colorectal cancers accounting for about 48% of all diagnoses in men. Furthermore, by 2040, the yearly incidence of new cancer cases is predicted to rise significantly to 29.9 million. Additionally, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, stated that approximately 1.9 million new cancer cases were diagnosed in the USA in 2022. Consequently, the increasing volume of cancer diagnoses is set to boost the oncology ablation market.

What Are The Emerging Segments Gaining Attention In The Oncology Ablation Market?

The oncology ablationmarket covered in this report is segmented –

1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation; Laparoscopic Ablation; Percutaneous Ablation

3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation; Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation; Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation; Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE; Transperineal IRE; Percutaneous IRE

What Key Innovation Trends Are Fueling Advancements In The Oncology Ablation Market?

Companies actively involved in the oncology ablation market are focused on developing groundbreaking products, encompassing advanced ablation systems that offer enhanced precision, integrated imaging technologies for real-time guidance, and strengthened safety features. These highly precise ablation systems are medical devices that utilize sophisticated technology to accurately target and eliminate abnormal tissue, such as tumors, while minimizing damage to surrounding healthy tissue. For instance, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, obtained US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, designed for treating painful bone metastases and benign tumors like osteoid osteoma. This enhanced system incorporates significant improvements, including the capability to use four internally cooled probes simultaneously, allowing for the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Which Leading Players Are Enhancing Their Oncology Ablation Market Presence Worldwide?

Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Region Is Projected To Lead The Oncology Ablation Market During The Forecast Period?

North America was the largest region in the oncology ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Oncology Ablation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2025, By The Business Research Company

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Immuno Oncology Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Oncology Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795